The HF group showed higher insulin levels than the C group (+75%, P<0.05) and both treatments countered the hyperinsulinemia caused by chronic HF intake (-34% for HF-α and -64% for HF-β, P<0.05). This evidence concerns the gene INS and hyperinsulinism.